- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT04906018
A Study to Collect Imaging Data for the Validation of the Intelligent Ultrasound's ScanNav Anatomy Peripheral Nerve Block (PNB) - US v1.0
Studie Overzicht
Toestand
Interventie / Behandeling
Gedetailleerde beschrijving
Background:
The American Society of Regional Anesthesia and Pain Medicine (ASRA) has published evidence-based assessment of ultrasound-guided regional anesthesia (Neal et al., 2010) concluding that ultrasound guidance is superior or equal to other non-ultrasound nerve localization techniques. A subsequent publication from ASRA (Neal et al., 2016), has strengthened their position of ultrasound guidance being superior than other methods, including for the reduction of local anesthetic systemic toxicity. However, ultrasound-guided regional anesthesia (UGRA) is a difficult technique to master. A key activity of UGRA is ultrasound image interpretation (Sites et al., 2009) which ScanNav Anatomy PNB is designed to support. The data collected during this study will be assessed by a panel of intended users (experts in UGRA) to evaluate the performance and safety of ScanNav Anatomy PNB device highlighting.
Statistical Methodology:
Validation analyses will be conducted once the data collection has been complete. The collected scans will be processed, and the device output will be generated post hoc. Device output will be presented with raw ultrasound side-by-side. A panel of at least three expert anesthesiologists will review and evaluate each processed scan. The majority view of the panel will be used to evaluate each endpoint for any given structure ScanNav Anatomy PNB is intended to highlight.
Data collection and scan processing:
40 different subjects will be scanned. The dataset will be balanced to contain approximately equal numbers of subjects with BMI<30 and BMI>= 30 kg/m2.
All data collection will be performed with FDA cleared general purpose ultrasound machine, ScanNav Anatomy PNB device will not be used during data collection.
Data characteristics for scan subjects (e.g., age and BMI) will be reported. Ultrasound scans for all 9 supported anatomical regions will be collected from both sides of each subject.
90 x 10s clips per supported anatomical region will be generated, consisting of:
- 80 x 10s scene clips: the block view (chosen by the expert scanner) together with the preceding 10 seconds of ultrasound scanning will be recorded (without the use of ScanNav Anatomy PNB)
- 10 x 10s non-scene clips: 10 second ultrasound scans will be recorded at non-optimum block views, chosen by the expert scanner to represent plausible scanning errors (without the use of ScanNav Anatomy PNB) Scenes and non-scenes will be analyzed separately. Unmodified ultrasound video and highlighted video (color overlay produced by ScanNav Anatomy PNB generated post-hoc) will be presented side-by-side to independent experts for data analysis.
Data analysis:
Every clip will be presented to a minimum of 3 independent expert reviewers. All clips from a single anatomical region will be reviewed by the same 3 reviewers. Experts may review more than one anatomical region, but not necessarily all anatomical regions. Thus, a range of experts will review all anatomical regions.
Reviewers will be asked structured questions to assess the highlighting of safety critical anatomical structures (see definitions later in document) and the performance of ScanNav Anatomy PNB output for each individual clip.
The majority opinion (at least 2/3) will be obtained to establish the overall panel opinion (e.g., yes/yes/no = yes) for each structure on each clip.
Data will be evaluated and presented by structure in each anatomical region and overall (i.e., total for each class; nerve, artery etc.).
Inter-rater agreement between the reviewers will be reported on an anatomical region basis.
Data will be presented as frequencies and presented as percent of total clips analyzed.
Data analysis will include stratification by subject age, BMI, and ultrasound machine to ensure consistency across these variables.
Studietype
Inschrijving (Werkelijk)
Contacten en locaties
Studie Locaties
-
-
Oregon
-
Portland, Oregon, Verenigde Staten, 97239
- Oregon Health & Science University
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Bemonsteringsmethode
Studie Bevolking
Beschrijving
Inclusion Criteria:
- Male or female, at least 18 years of age;
- Able to comprehend and sign the Informed Consent prior to enrolment in the study.
- Vaccinated against SARS-CoV-2
Exclusion Criteria:
- Aged <18 years of age;
- Unwilling or unable to provide informed consent.
- BMI> 39 kg/m2
- Known pathology of the area to be scanned
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
Cohorten en interventies
Groep / Cohort |
Interventie / Behandeling |
---|---|
volunteer group - BMI less than 30
Each subject with a BMI less than 30 will be randomly allocated to an ultrasound machine and an expert scanner who will perform the ultrasound scans of all supported anatomical regions.
|
Each subject will be randomly allocated to an ultrasound machine and an expert scanner who will perform the ultrasound scans of all supported anatomical regions.
|
volunteer group - BMI of 30 and above
Each subject with a BMI of 30 and above will be randomly allocated to an ultrasound machine and an expert scanner who will perform the ultrasound scans of all supported anatomical regions.
|
Each subject will be randomly allocated to an ultrasound machine and an expert scanner who will perform the ultrasound scans of all supported anatomical regions.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
---|---|---|
ScanNav Anatomy PNB highlighting misidentification of structures
Tijdsspanne: 6 months
|
Frequency of misidentification of structures [% of total, per anatomical region]
|
6 months
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
---|---|---|
ScanNav Anatomy PNB highlighting identification of structures
Tijdsspanne: 6 months
|
Frequency of correct identification of structures [% of total] and Frequency of non-identification of structures [% of total]
|
6 months
|
ScanNav Anatomy PNB safety issues
Tijdsspanne: 6 months
|
Frequency of safety issues [% of total]
|
6 months
|
ScanNav Anatomy PNB adverse events
Tijdsspanne: 6 months
|
Frequency of highlighting risking an adverse event [% of total]
|
6 months
|
Medewerkers en onderzoekers
Sponsor
Onderzoekers
- Hoofdonderzoeker: Glenn Woodworth, MD, Oregon Health and Science University
- Hoofdonderzoeker: James Bowness, MD, University of Oxford & Royal Gwent Hospital
Publicaties en nuttige links
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Andere studie-ID-nummers
- IU2021_AG_07
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
product vervaardigd in en geëxporteerd uit de V.S.
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .
Klinische onderzoeken op Ultrasound scans
-
University of CoimbraFundação para a Ciência e a TecnologiaNog niet aan het wervenStaar | Ultrasone therapie; complicatiesPortugal
-
Helse Nord-Trøndelag HFNorwegian University of Science and Technology; St. Olavs HospitalVoltooidHartinfarct | Tijdelijke ischemische aanval | Ischemische aanval, voorbijgaand | Cerebrovasculair ongeval | Cerebrovasculaire ApoplexieNoorwegen
-
ReCor Medical, Inc.Nog niet aan het wervenHart-en vaatziekten | Vaatziekten | Hypertensie
-
Sunnybrook Health Sciences CentreOnbekendPatiënten met moeilijke vasculaire toegang.
-
Carilion ClinicVirginia Polytechnic Institute and State UniversityWervingChronische pijn | Fibromyalgie | Complexe regionale pijnsyndromenVerenigde Staten
-
ReCor Medical, Inc.WervingHypertensieDuitsland, Nederland, België, Frankrijk, Monaco, Zwitserland, Verenigd Koninkrijk
-
Seno Medical Instruments Inc.Voltooid
-
IRCCS Fondazione Stella MarisUniversity of Pisa; Ministry of Health, Italy; Fondazione C.N.R./Regione Toscana...WervingCerebrale parese | Ontwikkelingsstoornis | Kinderneurologische aandoeningItalië
-
Scientific Institute San RaffaeleVoltooidLow Cardiac Output-syndroom | Ziekte van de mitralisklepItalië
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...Werving